CEFEPIME Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefepime, and when can generic versions of Cefepime launch?
Cefepime is a drug marketed by B Braun, Acs Dobfar, Astral, Chartwell Rx, Hikma, Hospira Inc, Qilu Antibiotics, Sagent Pharms Inc, Samson Medcl, and Baxter Hlthcare. and is included in eleven NDAs.
The generic ingredient in CEFEPIME is cefepime hydrochloride. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefepime
A generic version of CEFEPIME was approved as cefepime hydrochloride by ACS DOBFAR on March 20th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CEFEPIME?
- What are the global sales for CEFEPIME?
- What is Average Wholesale Price for CEFEPIME?
Summary for CEFEPIME
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Drug Prices: | Drug price information for CEFEPIME |
| What excipients (inactive ingredients) are in CEFEPIME? | CEFEPIME excipients list |
| DailyMed Link: | CEFEPIME at DailyMed |
US Patents and Regulatory Information for CEFEPIME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER | cefepime hydrochloride | INJECTABLE;INJECTION | 050821-001 | May 6, 2010 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Qilu Antibiotics | CEFEPIME HYDROCHLORIDE | cefepime hydrochloride | INJECTABLE;INJECTION | 203704-003 | Feb 1, 2016 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Baxter Hlthcare | CEFEPIME IN PLASTIC CONTAINER | cefepime hydrochloride | INJECTABLE;INJECTION | 050817-002 | Aug 5, 2008 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | CEFEPIME HYDROCHLORIDE | cefepime hydrochloride | INJECTABLE;INJECTION | 090291-002 | Dec 21, 2010 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Acs Dobfar | CEFEPIME HYDROCHLORIDE | cefepime hydrochloride | INJECTABLE;INJECTION | 065441-002 | Mar 20, 2008 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
